Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

DNA methyltransferase3a expression is an independent poor prognostic indicator in gastric cancer.

Cao XY, Ma HX, Shang YH, Jin MS, Kong F, Jia ZF, Cao DH, Wang YP, Suo J, Jiang J.

World J Gastroenterol. 2014 Jul 7;20(25):8201-8. doi: 10.3748/wjg.v20.i25.8201.

2.

Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer.

Jiang J, Jin MS, Kong F, Wang YP, Jia ZF, Cao DH, Ma HX, Suo J, Cao XY.

World J Gastroenterol. 2013 Jan 28;19(4):575-80. doi: 10.3748/wjg.v19.i4.575.

3.

Clinicopathological significance and prognostic value of DNA methyltransferase 1, 3a, and 3b expressions in sporadic epithelial ovarian cancer.

Bai X, Song Z, Fu Y, Yu Z, Zhao L, Zhao H, Yao W, Huang D, Mi X, Wang E, Zheng Z, Wei M.

PLoS One. 2012;7(6):e40024. doi: 10.1371/journal.pone.0040024. Epub 2012 Jun 29.

4.

Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer.

Yang J, Wei X, Wu Q, Xu Z, Gu D, Jin Y, Shen Y, Huang H, Fan H, Chen J.

Mol Med Rep. 2011 Nov-Dec;4(6):1139-43. doi: 10.3892/mmr.2011.578. Epub 2011 Aug 31.

PMID:
21887466
5.

Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.

Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS.

World J Gastroenterol. 2016 Apr 14;22(14):3852-9. doi: 10.3748/wjg.v22.i14.3852.

6.

Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.

Sun XR, Sun Z, Zhu Z, Guan HX, Li CY, Zhang JY, Zhang YN, Zhou H, Zhang HJ, Xu HM, Sun MJ.

World J Gastroenterol. 2015 May 7;21(17):5336-44. doi: 10.3748/wjg.v21.i17.5336.

7.

The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer.

Ding WJ, Fang JY, Chen XY, Peng YS.

Dig Dis Sci. 2008 Aug;53(8):2083-9. doi: 10.1007/s10620-007-0145-2. Epub 2008 Feb 6.

PMID:
18253830
8.

Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival.

Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang HB, Wu JJ.

Dig Dis Sci. 2010 Jun;55(6):1649-57. doi: 10.1007/s10620-009-0926-x. Epub 2009 Aug 19.

PMID:
19690958
9.

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.

Cao X, Cao D, Jin M, Jia Z, Kong F, Ma H, Wang Y, Jiang J.

BMC Gastroenterol. 2014 Sep 12;14:157. doi: 10.1186/1471-230X-14-157.

10.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

11.

Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.

Purkait S, Sharma V, Kumar A, Pathak P, Mallick S, Jha P, Sharma MC, Suri V, Julka PK, Suri A, Sharma BS, Sarkar C.

Exp Mol Pathol. 2016 Apr;100(2):312-20. doi: 10.1016/j.yexmp.2016.02.002. Epub 2016 Feb 15.

PMID:
26892683
12.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

13.

DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.

Mutze K, Langer R, Schumacher F, Becker K, Ott K, Novotny A, Hapfelmeier A, Höfler H, Keller G.

Eur J Cancer. 2011 Aug;47(12):1817-25. doi: 10.1016/j.ejca.2011.02.024. Epub 2011 Mar 31.

PMID:
21458988
14.

Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.

Jiao X, Lu HJ, Zhai MM, Tan ZJ, Zhi HN, Liu XM, Liu CH, Zhang DP.

World J Gastroenterol. 2013 Dec 28;19(48):9425-31. doi: 10.3748/wjg.v19.i48.9425.

15.

Prognostic significance of glutathione peroxidase 2 in gastric carcinoma.

Liu D, Sun L, Tong J, Chen X, Li H, Zhang Q.

Tumour Biol. 2017 Jun;39(6):1010428317701443. doi: 10.1177/1010428317701443.

PMID:
28631563
16.

Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.

Hu X, Huang Z, Liao Z, He C, Fang X.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6716-24. eCollection 2014.

17.

Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.

Zhang L, Qiu M, Jin Y, Ji J, Li B, Wang X, Yan S, Xu R, Yang D.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11084-91. eCollection 2015.

18.

Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.

Wang P, Shi Q, Deng WH, Yu J, Zuo T, Mei FC, Wang WX.

World J Gastroenterol. 2015 May 28;21(20):6271-9. doi: 10.3748/wjg.v21.i20.6271.

19.

Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.

Lee H, Yoon SO, Jeong WY, Kim HK, Kim A, Kim BH.

Hum Pathol. 2012 Oct;43(10):1704-10. doi: 10.1016/j.humpath.2011.12.019. Epub 2012 Apr 18.

PMID:
22520951
20.

MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.

Sakamoto N, Tsujimoto H, Takahata R, Cao B, Zhao P, Ito N, Shimazaki H, Ichikura T, Hase K, Vande Woude GF, Shinomiya N.

Cancer Sci. 2017 Mar;108(3):322-330. doi: 10.1111/cas.13146.

Supplemental Content

Support Center